Switching from Gilenya to Lemtrada could trigger MS activity
According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
Switching from Gilenya to Lemtrada could trigger MS activity
Switching from Gilenya to Lemtrada could trigger MS activity
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1149 Views
-
Last post by frodo
-
- 0 Replies
- 970 Views
-
Last post by frodo
-
- 0 Replies
- 1056 Views
-
Last post by NHE
-
- 1 Replies
- 1507 Views
-
Last post by ElliotB
-
- 5 Replies
- 13397 Views
-
Last post by gibbledygook